1. Home
  2. BY vs NNNN Comparison

BY vs NNNN Comparison

Compare BY & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BY

Byline Bancorp Inc.

HOLD

Current Price

$29.52

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$32.39

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BY
NNNN
Founded
1914
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
BY
NNNN
Price
$29.52
$32.39
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$33.67
N/A
AVG Volume (30 Days)
196.7K
37.8K
Earning Date
01-22-2026
04-28-2026
Dividend Yield
1.35%
N/A
EPS Growth
1.54
N/A
EPS
2.80
0.06
Revenue
$400,663,000.00
$8,185,146.00
Revenue This Year
$19.64
N/A
Revenue Next Year
$3.98
N/A
P/E Ratio
$10.61
$619.66
Revenue Growth
7.23
21.95
52 Week Low
$22.63
$5.18
52 Week High
$31.24
$55.65

Technical Indicators

Market Signals
Indicator
BY
NNNN
Relative Strength Index (RSI) 52.08 52.88
Support Level $29.72 $31.18
Resistance Level $31.00 $38.00
Average True Range (ATR) 0.54 4.77
MACD -0.17 0.02
Stochastic Oscillator 11.63 38.83

Price Performance

Historical Comparison
BY
NNNN

About BY Byline Bancorp Inc.

Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: